Skip to main content
. 2020 Apr 22;10:584. doi: 10.3389/fonc.2020.00584

Figure 1.

Figure 1

TNFα enhances luminal breast cancer cell proliferation by aromatase upregulation. TNFα is produced by adipose cells, TAM or tumor cells itself, and induces the expression of aromatase. This enzyme increases estradiol synthesis which binds to ER that, in turn, promotes luminal cancer cell proliferation. IL-10 and docetaxel and paclitaxel inhibit aromatase synthesis by reducing TNFα signaling. sTNFα, soluble TNFα; TAM, tumor-associated macrophages; E2, estradiol; ER, estrogen receptor.